Applied Biosystems 3500 Dx Series Genetic Analyzers now available in Asia Pacific Region

NewsGuard 100/100 Score

Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems™ 3500 Dx Series Genetic Analyzers, the first CE IVD-marked capillary electrophoresis system for nucleic acid analysis, are now available for sale in Australia, India, New Zealand, Singapore, and Taiwan.

“Life Technologies is proud to be working with these nations, providing them with enabling genetic sequencing systems and is committed to advancing human health and combating critical human diseases like cancer.”

The 3500 Dx Series Genetic Analyzers are intended for use in the analysis of human DNA or RNA for the detection of genetic changes that may lead to disease presence or susceptibility. The 3500 Series enables researchers to run up to 1,100 sequencing or 1,200 genotyping samples per day. It features a novel consumables design that incorporates the ability to track key information with radio frequency identification (RFID) tags, new optical and thermal sub-systems, and redesigned data collection and analysis software, creating a more cost-effective method for high-quality data analyses.

"We are very excited to see the 3500 Dx Genetic Analyzer be accepted and approved for sale across the Asia Pacific Region," said Mark Smedley, head of the Asia Pacific region for Life Technologies. "Life Technologies is proud to be working with these nations, providing them with enabling genetic sequencing systems and is committed to advancing human health and combating critical human diseases like cancer."

The 3500 Dx Series Genetic Analyzers are part of a broader portfolio of advanced genomic technologies that are built upon Applied Biosystems' legacy of providing platforms that are recognized for proven technology, reliability and performance. They provide an integrated solution that combines the instrument with Applied Biosystems reagents, consumables, software, and world class service and support.

The 3500 Dx platform is also available in the following European countries: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Luxembourg, the Netherlands, Norway, Poland, Spain, Sweden, Switzerland, and the United Kingdom.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Enhancer-gene mapping with SCENT method offers insights into disease mechanisms